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Rapid neutrophil recruitment is essential to 
combat pathogens (Nathan, 2006; Ley et al., 
2007; Phillipson and Kubes, 2011). However, 
excessive neutrophil accumulation causes tissue 
injury in many inflammatory disorders, including 
ischemia–reperfusion of the kidney (Bonventre 
and Weinberg, 2003). In most organs, neutro-
phils roll along postcapillary venules, then arrest, 
spread, crawl to endothelial cell junctions, and 
migrate into perivascular tissues (Ley et al., 2007; 
Nourshargh et al., 2010). Endothelial cell selec-
tins mediate rolling (McEver and Zhu, 2010). 
Neutrophil integrins, which are heterodimers 
composed of  and  subunits, enable arrest 
and crawling (Lefort and Ley, 2012). Signaling 
modulates neutrophil function (Zarbock et al., 
2011). Neutrophils rolling on P-selectin en-
gage P-selectin glycoprotein ligand-1 (PSGL-1), 
and neutrophils rolling on E-selectin engage 
PSGL-1 or CD44 (Zarbock et al., 2007; Yago 
et al., 2010b). These interactions trigger signals 
that convert the integrin L2 ectodomain 
from a bent to an extended conformation, 
which retains a closed headpiece with low af-
finity for ligands (Kuwano et al., 2010). The ex-
tended, low-affinity integrin slows rolling by 
reversibly interacting with intercellular adhesion 
molecule-1 (ICAM-1) on activated endothelial 
cells. Notably, PSGL-1–triggered, L2-mediated 
slow rolling requires neither intact actin filaments 
nor actomyosin-dependent tension (Shao et al., 
2012). Slow rolling velocities enable neutrophil 
CXCR2 to interact with endothelial-bound 
chemokines such as CXCL1, which signal con-
version of L2 into an extended conformation 
with an open, high-affinity headpiece ( Jung et al., 
1998; Lefort and Ley, 2012). The extended, 
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Neutrophil recruitment, mediated by 2 integrins, combats pyogenic infections but also 
plays a key role in ischemia–reperfusion injury and other inflammatory disorders. Talin 
induces allosteric rearrangements in integrins that increase affinity for ligands (activation). 
Talin also links integrins to actin and other proteins that enable formation of adhesions. 
Structural studies have identified a talin1 mutant (L325R) that perturbs activation without 
impairing talin’s capacity to link integrins to actin and other proteins. Here, we found that 
mice engineered to express only talin1(L325R) in myeloid cells were protected from renal 
ischemia–reperfusion injury. Dissection of neutrophil function in vitro and in vivo revealed 
that talin1(L325R) neutrophils had markedly impaired chemokine-induced, 2 integrin–
mediated arrest, spreading, and migration. Surprisingly, talin1(L325R) neutrophils exhibited 
normal selectin-induced, 2 integrin–mediated slow rolling, in sharp contrast to the defec-
tive slow rolling of neutrophils lacking talin1 or expressing a talin1 mutant (W359A) that 
blocks talin interaction with integrins. These studies reveal the importance of talin-mediated 
activation of integrins for renal ischemia–reperfusion injury. They further show that 
neutrophil arrest requires talin recruitment to and activation of integrins. However, al-
though neutrophil slow rolling requires talin recruitment to integrins, talin-mediated 
integrin activation is dispensable.
© 2015 Yago et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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A leucine residue (L325) in the talin head domain, located out-
side the interface with the rod domain (Song et al., 2012), 
forms a critical part of a hydrophobic region that interacts with 
two phenylalanines (F727 and F730 in 3) in the MP region 
(Wegener et al., 2007). A talin L325R mutation inhibits bind-
ing to the MP site but has little effect on the overall affinity of 
talin for the integrin. This mutation markedly reduces the abil-
ity of talin to increase tilting of the 3 TMD or to activate 
integrin IIb3. Indeed, mice expressing only talin1(L325R) in 
their platelets exhibit a failure to activate integrin IIb3 
(Haling et al., 2011) and, as a result, manifest defective platelet 
aggregation, impaired platelet-mediated clot retraction, and 
severe bleeding (Haling et al., 2011; Stefanini et al., 2014). These 
in vitro and in vivo data provide strong evidence for the impor-
tance of talin binding to the MP region for allosteric activation 
of 3 integrins. However, separable functions of 3 integrins 
analogous to 2 integrin–mediated slow rolling and arrest 
have not been identified.
Here, we report the impact of the talin1 L325R mutation 
on neutrophil 2 integrin function in vitro and in vivo. Mice 
expressing talin1(L325R) only in myeloid cells were protected 
from renal ischemia–reperfusion injury, and their neutrophils 
failed to undergo chemokine-induced arrest, spreading, and 
migration. Unexpectedly, the neutrophils exhibited normal 
selectin-triggered, L2-dependent slow rolling on ICAM-1. 
These data show that talin binding to the MP region of 2 
tails is essential for neutrophil-mediated ischemia–reperfusion 
injury and for chemokine-triggered neutrophil arrest, but not 
for selectin-triggered slow rolling.
RESULTS
Mice expressing talin1(L325R) in neutrophils are  
protected from kidney ischemia–reperfusion injury
To determine whether talin1(L325R) can activate 2 integrins 
in neutrophils, we crossed Tln1L325R/wt mice, which express 
WT talin1 on one allele and talin1(L325R) on the other allele, 
with Tln1f/fLysMCre+ mice, which make myeloid cells lack-
ing Tln1 on both alleles. Tln1L325R/fLysMCre+ progeny make 
myeloid cells with one allele lacking Tln1 and one allele ex-
pressing talin1(L325R). Tln1wt/fLysMCre+ littermate controls 
make myeloid cells with one allele lacking Tln1 and one allele 
expressing WT talin1. We used a similar strategy to generate 
Tln1W359A/fLysMCre+ mice that make myeloid cells with one 
allele lacking Tln1 and one allele expressing talin1(W359A). 
W359 in the talin1 head domain is located outside the inter-
face with the rod domain (Song et al., 2012). A W359A muta-
tion does not affect binding to the rod domain, but it markedly 
impairs binding to the high-affinity MD site on the integrin 
3 tail (Wegener et al., 2007; Stefanini et al., 2014). We used 
heterozygous mice because global expression of talin1(L325R) 
or talin(W359A) on both alleles causes embryonic lethality 
(Haling et al., 2011), as observed in mice globally lacking talin1 
(Monkley et al., 2000). Western blots with an antibody that 
recognizes both talin1 and talin2 confirmed deletion of talin1 
and no detectable talin2 in neutrophils from Tln1f/fLysMCre+ 
high-affinity integrin mediates arrest on ICAM-1 and post-arrest 
outside-in signaling that strengthens adhesion and induces spread-
ing (Yago et al., 2010b). Unlike slow rolling, arrest and spread-
ing require actin filaments and actomyosin-dependent tension 
(Shao et al., 2012). Current evidence suggests that both selectin 
and chemokine signaling must be blocked to prevent neutro-
phil recruitment in many acute-inflammation models (Zarbock 
et al., 2007, 2008; Mueller et al., 2010; Yago et al., 2010b; 
Stadtmann et al., 2011). However, it was reported that blocking 
only selectin signaling prevents neutrophil-mediated injury to 
the kidney during ischemia and reperfusion (Block et al., 2012).
A final common step in integrin activation is binding of 
talin to the cytoplasmic domain (tail) of the  subunit (Kim 
et al., 2011; Ye et al., 2014). Talin is a large cytosolic pro-
tein with a head domain and a rod domain that interact 
with each other (Critchley, 2009). Cellular signals disrupt 
these intramolecular interactions and recruit talin to the 
membrane. The talin head domain binds to  tails, whereas 
the rod domain binds to  tails, actin, and other proteins. 
Talin1 is the predominant isoform expressed in hematopoi-
etic cells. Talin1-deficient neutrophils cannot extend the 
L2 ectodomain in response to selectin or chemokine sig-
nals (Lefort et al., 2012). They are defective in both L2-
mediated slow rolling and arrest on ICAM-1. Kindlins, 
another group of cytoplasmic adaptors, bind to a different 
region of the  tail (Moser et al., 2009b; Ye et al., 2014). 
Kindlin-3 is the predominate isoform expressed in hemato-
poietic cells. In response to selectin or chemokine signals, 
kindlin-3–deficient neutrophils extend the L2 ectodo-
main but fail to open the headpiece (Lefort et al., 2012). 
Therefore, they exhibit L2-dependent slow rolling but 
not arrest (Moser et al., 2009a; Lefort et al., 2012). These 
results, in conjunction with other studies (Bachir et al., 2014; 
Sun et al., 2014), suggest that kindlins facilitate talin-mediated 
integrin activation. Kindlins also increase the clustering of 
talin-activated integrins to augment adhesion strength (Ye et al., 
2013), which in turn, stabilizes the open headpiece and pro-
motes integrin outside-in signaling (Feigelson et al., 2011; 
Moretti et al., 2013; Xue et al., 2013).
Studies of platelet integrin IIb3 have illuminated how 
talin binding to  tails initiates integrin activation. The talin 
head domain binds with high affinity to a membrane-distal 
(MD) motif on the  tail. This facilitates binding to a low- 
affinity, membrane-proximal (MP) site on the  tail (Vinogra-
dova et al., 2002; Wegener et al., 2007). The MD and MP 
sequences are highly conserved in tails of  subunits. Talin bind-
ing to the MP region initiates integrin activation by two mecha-
nisms. First, it weakens a juxtamembrane salt bridge between 
the  and  tails (Anthis et al., 2009; Saltel et al., 2009). Sec-
ond, it stabilizes an  helix in the MP region to form a con-
tinuous  helix from the  transmembrane domain (TMD) 
into the MP region, and positions a basic patch in talin to 
bind to membrane phospholipids (Wegener et al., 2007; Anthis 
et al., 2009). This tripartite interaction increases the tilting 
angle of the 3 TMD, destabilizing IIb-3 TMD interac-
tions that result in allosteric activation (Kim et al., 2012). 
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mutation of talin1 in myeloid cells did not cause compensa-
tory expression of talin2. Anti–2 integrin antibody equiva-
lently coprecipitated talin1 and talin1(L325R), but not 
talin1(W359A), from lysates of CXCL1-stimulated neutrophils 
(Fig. 1 B). This finding indicates that talin1(L325R), unlike 
talin1(W359A), retains its ability to bind to the MD site 
of the 2 integrin tail, as previously demonstrated for 3 in-
tegrins (Wegener et al., 2007; Haling et al., 2011; Stefanini et al., 
2014). Mice of all genotypes were healthy and bred normally 
in the absence of challenge. Peripheral blood neutrophil 
counts were similarly elevated in Tln1f/fLysMCre+ and Tln1L325R/f 
LysMCre+ mice, but to a lesser degree than in Itgb2tm2Bay/J 
(2 integrin–deficient) mice (Table 1). Other blood counts 
were comparable in all genotypes (Table 1).
Neutrophils contribute to kidney ischemia–reperfusion 
injury in mice (Singbartl et al., 2000; Singbartl and Ley, 2000; 
Bonventre and Weinberg, 2003; Li et al., 2010; Herter et al., 
2014). We subjected mice to sham surgery or to surgery that 
included a 30-min clamp of both renal pedicles, followed by 
reperfusion for 24 h. In control mice, ischemia–reperfusion, 
but not sham surgery, markedly increased neutrophil infiltra-
tion and tubular necrosis in the kidneys (Fig. 2, A–D). Ischemia–
reperfusion also elevated creatinine levels in plasma, indicating 
decreased glomerular filtration from tissue injury (Fig. 2 E). 
In contrast, ischemia–reperfusion did not induce neutro-
phil infiltration in Tln1f/fLysMCre+ or Tln1L325R/fLysMCre+ 
mice (Fig. 2, A and B). Furthermore, Tln1f/fLysMCre+ and 
Tln1L325R/fLysMCre+ mice exhibited significantly less tubular 
necrosis (Fig. 2, C and D) and elevation of plasma creatinine 
(Fig. 2 E), similar to that observed in neutrophil-depleted 
mice (Grenz et al., 2012). The neutrophil-independent com-
ponent of acute kidney injury is primarily due to inadequate 
ATP production in epithelial cells during ischemia (Sharfuddin 
and Molitoris, 2011). We also observed markedly reduced 
neutrophil recruitment in kidneys of CXCR2-deficient 
(Cxcr2/) mice, suggesting a major role for chemokine stim-
ulation of neutrophils in this model (Fig. 2 A). These results 
demonstrate that blocking talin-mediated integrin activation 
in neutrophils by deleting talin1 or by the talin1(L325R) mu-
tation reduces kidney ischemia–reperfusion injury.
Neutrophils expressing talin1(L325R) exhibit  
impaired entry into a site of inflammation
Selectins, chemokines, and 2 integrins promote neutro-
phil migration into the thioglycollate-challenged perito-
neum (Robinson et al., 1999; Call et al., 2001; Smith et al., 
2004), a classical model of acute inflammation. During the 
first 4 h after challenge, neutrophil recruitment is primarily 
dependent on integrin L2 rather than M2 (Coxon et al., 
1996; Lu et al., 1997; Henderson et al., 2003). In control 
mice, we observed normal neutrophil migration into the peri-
toneum 4 h after thioglycollate injection, which was par-
tially reduced by pretreating mice with pertussis toxin (PTx) 
to disable Gi-coupled chemokine receptors (Fig. 3 A). 
Migration was markedly decreased in both Tln1f/fLysMCre+ 
and Tln1L325R/fLysMCre+ mice, even without PTx pretreatment 
Figure 1. Murine neutrophils express equivalent levels of talin1, 
talin1(L325R), or talin1(W359A). (A, top) Representative Western blot 
of neutrophil lysates from the indicated genotype, probed with mAb 8d4, 
which recognizes both talin1 and talin2, or probed with rabbit anti–-
actin IgG. (bottom) Quantification of the talin/-actin ratio by densitom-
etry. (B) Neutrophils of the indicated genotype were incubated with or 
without CXCL1, lysed, and immunoprecipitated (IP) with control (Ctrl) or 
anti–2 integrin mAb. Immunoprecipitates were analyzed by Western 
blotting (immunoblot, IB) with anti-talin and anti–2 integrin antibodies. 
The data in A represent the mean ± SEM from three experiments. The data 
in B are representative of three experiments. *, P < 0.01, as determined by 
unpaired Student’s t test.
mice compared with neutrophils from Tln1f/fLysMCre con-
trol mice, which express WT talin1 on both alleles (Fig. 1 A). 
Neutrophils from Tln1wt/fLysMCre+, Tln1L325R/fLysMCre+, 
or Tln1W359A/fLysMCre+ mice expressed 50% less talin, 
consistent with only one functional allele (Fig. 1 A). Quanti-
tative PCR detected no mRNA for talin2 in bone marrow 
leukocytes of all genotypes, whereas mRNA for talin2 was 
readily detected in brain (unpublished data). Thus, deletion or 
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of L2. Selectin signals induce an extended conformation 
with a closed headpiece that retains low affinity for ICAM-1, 
whereas chemokine signals induce an extended conforma-
tion with an open, high-affinity headpiece (Kuwano et al., 
2010). We confirmed published observations (Lefort et al., 
2012) that talin1-deficient neutrophils from Tln1f/fLysMCre+ 
mice rolling on E-selectin (wall shear stress of 1 dyn/cm2) 
failed to undergo either selectin-mediated slow rolling (Fig. 4 A) 
or CXCL1-mediated arrest on ICAM-1 (Fig. 4 D). Similar 
observations were made with neutrophils rolling on P-selectin 
(unpublished data). The arrest deficit was comparable to that of 
WT neutrophils treated with PTx to block Gi-coupled che-
mokine receptors (Fig. 4 G) or of CXCR2-deficient neutrophils 
(Fig. 4 H). Neutrophils from Tln1W359A/fLysMCre+ mice exhib-
ited neither E-selectin–mediated slow rolling (Fig. 4 B) nor 
CXCL1-mediated arrest on ICAM-1 (Fig. 4 E), indicating 
that talin must bind to the MD site of the 2 tail for both 
slow rolling and arrest.
Based on the protection from kidney ischemia–reperfusion 
injury and the absence of thioglycollate-induced neutrophil 
recruitment, we predicted that neutrophils from Tln1L325R/f 
LysMCre+ mice would resist talin-mediated conformational 
change in response to selectin or chemokine signals. Indeed, 
neutrophils from Tln1L325R/fLysMCre+ mice rolling on E-se-
lectin did not undergo CXCL1-mediated arrest and spreading 
on ICAM-1 (Fig. 4 F). Unexpectedly, however, they mani-
fested normal E-selectin–mediated slow rolling on ICAM-1 
(Fig. 4 C). Similar observations were made with neutrophils 
rolling on P-selectin (unpublished data). These data suggest 
that defective binding to the MP site on the 2 tail does not 
prevent integrin-associated talin1(L325R) from supporting 
slow rolling on ICAM-1.
(Fig. 3 A). To compare migration of neutrophils from different 
genotypes in the same mouse, we mixed control leukocytes 
labeled with a red dye with an equal number of control, 
Tln1f/fLysMCre+, or Tln1L325R/fLysMCre+ leukocytes labeled 
with a green dye. The cell mixture was injected intravenously 
into WT mice 2 h after injecting thioglycollate intraperitone-
ally. After another 2 h, a blood sample was obtained and peri-
toneal cells were collected. Neutrophils were counted for red 
and green fluorescence. Red and green cells in blood main-
tained a 1:1 ratio, confirming injection and survival of equal 
numbers of each population (Fig. 3 B). Mixtures of red and 
green control neutrophils entered the peritoneum in equal 
numbers. However, far fewer green Tln1f/fLysMCre+ or 
Tln1L325R/fLysMCre+ neutrophils entered the peritoneum than 
red control neutrophils (Fig. 3 B). These results demon-
strate that blocking talin-mediated 2 integrin activation, by 
deleting talin1 or by the talin1(L325R) mutation, prevents 
neutrophil recruitment into the peritoneum after a potent 
inflammatory stimulus.
Neutrophils expressing talin1(L325R) manifest normal 
selectin-induced, 2 integrin–mediated slow rolling  
on ICAM-1 and defective chemokine-induced, 2  
integrin–mediated arrest and spreading on ICAM-1
Murine bone marrow leukocytes roll on immobilized P- or 
E-selectin; >90% of the rolling cells are neutrophils. Selectin 
engagement induces integrin L2-mediated slow rolling on 
coimmobilized ICAM-1. Coimmobilized CXCL1 induces 
L2-mediated arrest and spreading on ICAM-1 (Miner et al., 
2008; Yago et al., 2010b). Slow rolling and arrest are func-
tional reporters of two distinct talin-mediated conformations 
Table 1. Peripheral blood counts
Genotype WBC NE LY MO RBC Hgb PLT
×103/µl ×103/µl ×103/µl ×103/µl ×103/µl g/dl ×103/µl
WT  
(C57BL/6J) 
 n = 15
4.6 ± 0.5 0.9 ± 0.1 3.6 ± 0.5 0.1 ± 0.0 10.1 ± 0.5 14 ± 1.5 1.0 ± 0.1
Itgb2tm2Bay/J (C57BL/6J)  
n = 5
13.6 ± 1.0a 6.7 ± 1.0a 6.4 ± 1.0 0.3 ± 0.1 12.1 ± 0.5 12 ± 1.0 0.9 ± 0.1
Tln1f/fLysMCre  
n = 7
4.5 ± 0.5 1.0 ± 0.2 3.4 ± 0.5 0.1 ± 0.1 11.0 ± 1.0 11 ± 1.5 1.1 ± 0.1
Tln1f/fLysMCre+  
n = 7
9.0 ± 1.0b 4.6 ± 1.0b 4.1 ± 1.0 0.3 ± 0.1 10.0 ± 0.5 12 ± 1.5 0.9 ± 0.1
Tln1f/wtLysMCre+  
n = 7
5.1 ± 0.5 1.2 ± 0.3 3.8 ± 0.1 0.1 ± 0.0 9.8 ± 0.5 13 ± 1.5 1.1 ± 0.1
Tln1f/L325RLysMCre+  
n = 7
8.3 ± 1.0c 4.0 ± 1.0c 4.0 ± 1.0 0.2 ± 0.0 10.5 ± 1.0 11 ± 1.0 0.9 ± 0.1
Hgb, hemoglobin; LY, lymphocytes; MO, monocytes; NE, neutrophils; PLT, platelets; RBC, red blood cells; WBC, white blood cells (total leukocytes). Itgb2tm2Bay/J, 2 integrin–
deficient mice in C57BL/6J background. The data represent the mean ± SEM.
aP < 0.01 vs. WT.
bP < 0.01 vs. Tln1f/fLysMCre.
cP < 0.01 vs. Tln1f/wtLysMCre+.
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ICAM-1 under static or flow conditions, in the presence or 
absence of selectins.
Neutrophils expressing talin1(L325R) exhibit normal  
E–selectin–induced, 2 integrin–mediated slow  
rolling in venules
To determine whether talin1(L325R) can mediate 2 integrin–
dependent slow rolling in vivo, we used intravital microscopy 
to visualize neutrophil rolling in venules of the cremaster 
muscle 4 h after intrascrotal injection of TNF, which induces 
endothelial expression of P- and E-selectin (Kunkel and Ley, 
To examine the contribution of talin1(L325R) to che-
mokine-induced 2 integrin activation independently of 
selectins, we incubated neutrophils under static conditions 
on control or ICAM-1–immobilized surfaces with or with-
out coimmobilized CXCL1. Unbound neutrophils were 
then removed by perfusing cell-free buffer at low shear 
stress (0.25 dyn/cm2). Control neutrophils, but not neutro-
phils lacking talin1 or expressing talin1(L325R), adhered 
specifically to ICAM-1 coimmobilized with CXCL1 (Fig. 4 I). 
Collectively, these results indicate that talin1(L325R) does 
not support chemokine-induced neutrophil adhesion to 
Figure 2. Mice expressing talin1(L325R) in neutrophils are protected from kidney ischemia–reperfusion injury. Mice of the indicated genotype 
were subjected to sham surgery or surgery that included a 30-min clamp of both renal pedicles to induce ischemia, followed by release of the clamp to 
permit reperfusion for 24 h. (A) Neutrophils infiltrating the kidneys were quantified by flow cytometry. (B) Immunofluorescence of representative kidney 
sections. Neutrophils were stained with anti-Ly6G mAb. Nuclei were counterstained with DAPI. Bar, 10 µm. (C) Representative kidney outer medulla sec-
tions stained with hematoxylin and eosin. Bar, 50 µm. (D) Tubular necrosis was quantified by epithelial karyolysis, necrotic debris, and cast formation as 
described in Materials and methods. (E) Creatinine levels in plasma. At least five mice were in each experimental group. The data in B and C are representative 
of five experiments. The data in A, D, and E represent the mean ± SEM from five experiments. *, P < 0.01, as determined by unpaired Student’s t test.
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and the membranes of neutrophils lacking talin1 or expressing 
talin1(L325R) with another fluorescent dye. A 1:1 mixture of 
labeled control and mutant neutrophils was injected intra-
venously into WT mice subjected to kidney ischemia for 
30 min, followed by reperfusion for 4 h. FITC-conjugated 
dextran was injected to visualize blood vessels. Spinning-disk 
confocal microscopy of the renal cortex was used to visualize 
rolling of labeled neutrophils in the same venules. Serial in-
jection of blocking mAbs to P- and E-selectin detached all 
rolling cells (unpublished data). Injecting only anti–P-selectin 
mAb permitted specific study of E-selectin–mediated rolling 
and signaling (Fig. 5, E and F). Labeled Tln1f/fLysMCre+ neu-
trophils rolled faster than control neutrophils in the same 
venules, and injection of anti–2 integrin mAb did not alter 
their velocities (Fig. 5 E). In contrast, Tln1L325R/fLysMCre+ 
neutrophils rolled slowly like control neutrophils in the same 
venules, and their velocities increased after injecting anti–2 
integrin mAb (Fig. 5 F). These data demonstrate that even 
when talin1-mediated slow rolling is intact, neutrophils re-
quire talin-mediated integrin activation to mediate kidney 
injury during ischemia–reperfusion.
Neutrophils expressing talin1(L325R) do not arrest  
in venules and do not emigrate out of venules
Intrascrotal injection of TNF increases expression of CXCL1 on 
venular surfaces in the cremaster muscle (Griffin et al., 2012; Yao 
et al., 2013). Endothelial CXCL1 activates integrin L2 on 
slow-rolling neutrophils, inducing them to subsequently arrest 
and then emigrate out of venules in response to CXCL1 gra-
dients (Phillipson et al., 2006; Massena et al., 2010; McDonald 
1996). Hemodynamic and microvascular parameters in venules 
(Yago et al., 2010b) were equivalent in all genotypes (unpub-
lished data). We injected PTx intravenously to block chemokine 
signaling through Gi-coupled receptors, and measured rolling 
velocities in the same venules before and after sequentially 
injecting blocking mAbs to P-selectin and 2 integrins. Anti– 
P-selectin mAb did not increase velocities, consistent with the 
dominance of E-selectin for rolling in this model (Kunkel and 
Ley, 1996). In control mice, Anti–2 integrin mAb increased 
rolling velocities, confirming that slow rolling requires integrins 
(Fig. 5, A and B). As reported previously (Lefort et al., 2012), 
Tln1f/fLysMCre+ neutrophils rolled faster than control neutro-
phils, and anti–2 integrin mAb did not alter their velocities 
(Fig. 5 A). In sharp contrast, Tln1L325R/fLysMCre+ neutrophils 
rolled slowly like control neutrophils, and their velocities in-
creased after injecting anti–2 integrin mAb (Fig. 5 B).
To directly compare rolling neutrophils from different 
genotypes in the same venules, we injected irradiated WT 
mice with WT LysM-GFP+ bone marrow cells mixed with 
an equal number of nonfluorescent bone marrow cells from 
each genotype. After reconstitution, we measured rolling 
velocities of fluorescent and nonfluorescent neutrophils in 
the same TNF-challenged venules in the cremaster muscle of 
mice pretreated with PTx and anti–P-selectin mAb. We con-
firmed loss of 2 integrin–dependent slow rolling in Tln1f/f 
LysMCre+ neutrophils (Fig. 5 C) but retention of slow rolling 
in Tln1L325R/fLysMCre+ neutrophils (Fig. 5 D). These data 
demonstrate that talin1(L325R) mediates selectin-induced, 
2 integrin–mediated slow rolling in vivo as well as in vitro.
To examine neutrophil rolling in the kidney, we labeled 
the membranes of control neutrophils with one fluorescent dye 
Figure 3. Neutrophils expressing talin1(L325R) exhibit impaired entry into a site of inflammation. (A) Untreated or PTx-pretreated mice of the 
indicated genotype were injected with thioglycollate intraperitoneally. After 4 h, peritoneal cells were collected, and the number of neutrophils was mea-
sured by flow cytometry. (B) Bone marrow leukocytes from control mice (Tln1f/fLysMCre or Tln1f/wtLysMCre+) or experimental mice (Tln1f/fLysMCre+ or 
Tln1f/L325RLysMCre+) were labeled with red (PKH26) or green (PKH67) dye. The labeled cells were resuspended at 108 cells/ml and mixed at a 1:1 ratio. Re-
cipient mice were injected with thioglycollate intraperitoneally and, after 2 h, with 200 µl of the labeled cell mixture retroorbitally. After another 2 h, 
blood was collected. The mice were sacrificed, and peritoneal cells were collected. Neutrophils in blood and peritoneal exudate were counted. The data 
were plotted as the ratio of PKH26-labeled neutrophils from the experimental population compared with PKH67-labeled neutrophils from the control 
population. The data represent the mean ± SEM from five experiments, with at least five mice in each experimental group. *, P < 0.01 as determined by 
unpaired Student’s t test.
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mice with PTx to inhibit chemokine signaling reduced arrest 
and emigration by 50%, as noted previously (Yago et al., 
2010b). In contrast, neutrophil arrest and emigration were 
markedly impaired in both Tln1f/fLysMCre+ and Tln1L325R/f 
LysMCre+ mice, even without PTx pretreatment (Fig. 6, 
A and B). These data establish that even when talin1-mediated 
slow rolling is intact, talin-mediated integrin activation is re-
quired to support neutrophil arrest and emigration in vivo.
et al., 2010). Current evidence suggests that both selectin sig-
naling (to convert L2 to an extended conformation with low 
affinity for ICAM-1) and chemokine signaling (to convert 
L2 to an extended conformation with high affinity for 
ICAM-1) must be blocked to prevent neutrophil arrest and emi-
gration (Zarbock et al., 2007, 2008; Mueller et al., 2010; Yago et al., 
2010b; Stadtmann et al., 2011). We observed normal neutrophil 
arrest and emigration in control mice (Fig. 6, A and B). Pretreating 
Figure 4. Neutrophils expressing talin1(L325R) manifest normal selectin-induced, 2 integrin–mediated slow rolling on ICAM-1 and de-
fective chemokine-induced, 2 integrin–mediated arrest and spreading on ICAM-1. (A–C) Velocities of neutrophils of the indicated genotype 
rolling on E-selectin with or without coimmobilized ICAM-1 in the presence or absence of anti-ICAM-1 mAb. (D–H) Numbers of neutrophils of the indi-
cated genotype rolling, arrested and round, or arrested and spread on coimmobilized E-selectin, ICAM-1, and CXCL1. The neutrophils in G were pretreated 
with PTx to block chemokine signaling through Gi-coupled receptors. The wall shear stress in A–H was 1 dyn/cm2. (I) Numbers of neutrophils of the indi-
cated genotype that adhered to control (Ctrl) or ICAM-1–immobilized surfaces with or without coimmobilized CXCL1 under static conditions. The data 
represent the mean ± SEM from five experiments, with at least five mice in each experimental group. *, P < 0.01, as determined by unpaired Student’s t test.
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Figure 5. Neutrophils expressing talin1(L325R) exhibit normal E-selectin–induced, 2 integrin–mediated slow rolling in venules. 
(A and B) Velocities of neutrophils rolling in TNF-stimulated venules of cremaster muscle in mice of the indicated genotypes, measured before and after 
injecting a blocking mAb to P-selectin and then a blocking mAb to 2 integrins. The mice were pretreated with PTx to block chemokine signaling through 
Gi-coupled receptors. (C and D) Lethally irradiated WT mice were injected with WT LysM-GFP+ bone marrow cells mixed with an equal number of GFP-
negative cells of the indicated genotype. After eight weeks, the mice were treated with PTx and anti–P-selectin mAb, and rolling velocities of GFP-positive 
and GFP-negative neutrophils were measured in the same TNF-stimulated venules before and after injecting anti–2 integrin mAb. (E and F) Velocities of 
differentially labeled bone marrow leukocytes from mice of the indicated genotype rolling in venules of the kidney cortex subjected to ischemia–reperfusion, 
before and after sequentially injecting blocking mAbs to P-selectin and 2 integrins. Representative fluorescent images (before injection of anti–2 inte-
grin mAb) illustrate distances rolled by control and mutant leukocytes over 5 s in the same venule visualized with FITC-dextran, outlined by the dashed 
line. The white arrow indicates the path of each rolling leukocyte. Bar, 10 µm. The data represent the mean ± SEM from five experiments, with at least five 
mice in each experimental group. *, P < 0.01 as determined by unpaired Student’s t test.
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integrin–dependent adhesion strengthening requires talin- 
induced integrin activation. The activation requirement can be 
bypassed by exogenously activating integrins with Mn2+. When 
talin is absent, however, Mn2+ activation is insufficient for ad-
hesion strengthening, most likely because talin is also required 
to link integrins to the actin cytoskeleton.
DISCUSSION
Our results document an essential role for talin1-mediated 
activation of 2 integrins during renal ischemia–reperfusion 
injury. They also reveal separable talin effects on neutrophil 
2 integrin function. Talin1-dependent neutrophil slow roll-
ing is not sufficient for arrest on ICAM-1 or for subsequent 
neutrophil entry into an inflammatory site and resulting renal 
ischemia–reperfusion injury; the latter two events require 
talin-mediated integrin activation.
Tln1L325R/fLysMCre+ and control neutrophils mediated 
equivalent selectin-induced, 2 integrin–mediated slow roll-
ing in vitro and in vivo (Figs. 4 and 5). This suggests similar 
conformations of L2 in neutrophils of both genotypes. 
Reporter mAbs for human 2 integrins indicate that this 
conformation involves ectodomain extension without head-
piece opening (Kuwano et al., 2010). Extending human L2 
while retaining a closed headpiece also permits transfected 
cells to roll on ICAM-1 (Salas et al., 2004). However, talin1 
(L325R) might induce subtle rearrangements of the bent L2 
ectodomain that permit rapid binding to ICAM-1 without 
full extension.
The adhesive defects of Tln1L325R/fLysMCre+ neutrophils 
are similar but not identical to those of kindlin-3–deficient 
neutrophils (Lefort et al., 2012). Both exhibit selectin-induced, 
2 integrin–mediated slow rolling but not chemokine-induced, 
2 integrin–mediated arrest. Integrin outside-in signaling, 
measured as spreading on anti–integrin mAb or on physiologi-
cal ligands when integrins are artificially activated, is defective 
in kindlin-3–deficient neutrophils or platelets (Moser et al., 
2008; Moser et al., 2009a; Xue et al., 2013) but normal in 
Talin1(L325R) strengthens adhesion when  
extracellular Mn2+ activates 2 integrins
Neutrophil adhesion to immobilized anti–2 integrin mAb ac-
tivates SFKs, spleen tyrosine kinase (Syk), Vav guanine nucleo-
tide-exchange factors, and other mediators that rearrange the 
actin cytoskeleton and induce spreading (Gakidis et al., 2004; 
Mócsai et al., 2006; Abram and Lowell, 2009). Neutrophils 
lacking talin1 or expressing talin1(L325R) also spread nor-
mally on anti–2 integrin mAb (Fig. 7, A and B). The Src 
family kinase (SFK) inhibitor PP2, but not its inactive ana-
logue PP3, blocked spreading. Thus, 2 integrin outside-in 
signaling does not require talin, consistent with results ob-
tained with other integrins (Arias-Salgado et al., 2005; Zhang 
et al., 2008).
Clot retraction supported by platelet integrin IIb3 re-
quires both talin1 (Haling et al., 2011) and outside-in sig-
naling by SFKs and downstream components (Suzuki-Inoue 
et al., 2007). Talin1(L325R) supports clot retraction when in-
tegrin IIb3 is activated by extracellular Mn2+, because it 
retains the capacity to link integrins to the actin cytoskeleton 
(Haling et al., 2011). By analogy, we hypothesized that Mn2+ 
activation of 2 integrins would enable Tln1L325R/fLysMCre+ 
neutrophils to resist shear-induced detachment from ICAM-1. 
To test this hypothesis, we introduced leukocytes of differ-
ent genotypes at low shear stress for 5 min into flow chambers 
coated with ICAM-1, which binds to integrins L2 and 
M2, or to fibrinogen, which binds to M2. Mn2+ was 
added to the buffer to activate 2 integrins. We observed sim-
ilar Mn2+-dependent adhesion of Tln1f/fLysMCre+, Tln1L325R/f 
LysMCre+, or control neutrophils to ICAM-1 or fibrinogen 
(Fig. 7, C and E). To measure adhesion strength, we intro-
duced cell-free buffer and measured adherent cells remaining 
after each step-wise increase in shear stress. Tln1L325R/fLy-
sMCre+ neutrophils resisted detachment to the same extent as 
control cells. In sharp contrast, we observed greater shear-
induced detachment of talin-deficient Tln1f/fLysMCre+ neu-
trophils (Fig. 7, D and F). These data demonstrate that 2 
Figure 6. Neutrophils expressing talin1(L325R) do not arrest in venules and do not emigrate out of venules. (A) Numbers of firmly adherent 
neutrophils within venules and (B) numbers of emigrated neutrophils outside venules in TNF-stimulated cremaster muscle. As indicated, some mice were 
pretreated with PTx to block chemokine signaling through Gi-coupled receptors. The data represent the mean ± SEM from five experiments, with at least 
five mice in each experimental group. *, P < 0.01 as determined by unpaired Student’s t test.
1276 Talin-mediated 2 integrin activation | Yago et al.
Figure 7. Talin1(L325R) strengthens adhesion when extracellular Mn2+activates 2 integrins. (A and B) Numbers of neutrophils of the indicated 
genotype adherent and round or adherent and spread on immobilized anti–2 integrin mAb. Neutrophils were pretreated with buffer only, the SFK inhibi-
tor PP2, or the inactive analogue PP3. (C) Numbers of neutrophils of the indicated genotype adherent to a control (Ctrl) surface or to immobilized ICAM-1 
at low wall shear stress (0.25 dyn/cm2). As indicated, 2 integrins were activated with extracellular MnCl2 or pretreated with PP3 or PP2. (D) Adhesion of 
MnCl2-treated neutrophils of the indicated genotype at 0.25 dyn/cm2 was measured as in panel C. The wall shear stress was then increased step-wise 
every 30 s, and the percentage of remaining adherent cells was determined. (E) Numbers of neutrophils of the indicated genotype adherent to a control 
(Ctrl) surface or to immobilized fibrinogen at low wall shear stress (0.25 dyn/cm2). As indicated, 2 integrins were activated with extracellular MnCl2 or 
pretreated with PP3 or PP2. (F) Adhesion of MnCl2-treated neutrophils of the indicated genotype to fibrinogen at 0.25 dyn/cm2 was measured as in E. The 
wall shear stress was then increased step-wise every 30 s, and the percentage of remaining adherent cells was determined. The data represent the mean 
± SEM from five experiments, with at least five mice in each experimental group. *, P < 0.01 compared with Tln1f/fLysMCre (PP2) or Tln1f/fLysMCre+ neu-
trophils as determined by unpaired Student’s t test.
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Stadtmann et al., 2011). However, these studies relied on in-
hibitors or gene knockouts that impair integrin-triggered 
outside-signals, as well as PSGL-1- or CD44-triggered inside-
out signals. Both pathways share many features that canonical 
immunoreceptors use, including activation of SFKs and Syk 
and recruitment of SH2-domain–containing leukocyte protein 
of 76-kD (SLP-76), adhesion- and degranulation-promoting 
adaptor protein (ADAP), and other adaptors (Abram and Lowell, 
2009; Zarbock et al., 2011). Mice with neutrophils lacking 
SLP-76 or ADAP are protected from renal ischemia–reperfusion 
injury, which was attributed solely to inhibiting selectin sig-
naling (Block et al., 2012). However, renal protection in these 
mice probably resulted, at least in part, from inhibiting outside-in 
signaling by chemokine-activated integrins bound to ICAM-1 
or other ligands. Defining the physiological relevance of selectin-
triggered activation of 2 integrins will require methods to 
block signaling through selectin ligands, e.g., PSGL-1, without 
affecting integrin outside-in signaling. Mechanistic insights 
from such studies may reveal new targets for antiinflamma-
tory drugs.
MATERIALS AND METHODS
Reagents. Murine P- and E-selectin IgM Fc chimeras and control murine 
CD45-IgM Fc chimera were described previously (Xia et al., 2002; Yago et al., 
2010a). Murine ICAM-1 Fc, CXCL1, and TNF were purchased from R&D 
Systems. Rat anti–murine E-selectin mAb 9A9 and anti–murine P-selectin 
mAb RB40.34 have been previously described (Labow et al., 1994; Ley 
et al., 1995). The following mAbs to murine proteins were purchased from 
BD: rat anti-integrin L2 (M17/4), rat anti-M2 (M1/70), rat anti–2 
integrin (GAME-46), hamster anti–ICAM-1 (3E2), and biotinylated rat 
anti–murine Ly6G. Nonbiotinylated rat anti–murine Ly6G mAb was pur-
chased from BioLegend. Murine mAb 8d4, which recognizes human and 
murine talin1 and talin2, murine fibrinogen, FITC-dextran (150 kD), and 
PKH26, PKH67, and CellVue Claret fluorescent dyes were purchased from 
Sigma-Aldrich. Rabbit polyclonal anti–-actin IgG was purchased from Cell 
Signaling Technology. Rabbit polyclonal anti–2 integrin antibody was pur-
chased from Santa Cruz Biotechnology, Inc. Alexa Fluor 488–conjugated don-
key anti–rat IgG antibody was purchased from Invitrogen. HRP-conjugated 
goat anti–murine IgG and goat anti–rabbit IgG were purchased from Thermo 
Fisher Scientific.
Mice. All mouse experiments were performed in compliance with protocols 
approved by the Institutional Animal Care and Use Committee of the Okla-
homa Medical Research Foundation. C57BL/6J mice were purchased from 
The Jackson Laboratory. Mice lacking the integrin 2 subunit (Itgb2tm2Bay/J) 
and mice lacking the chemokine receptor CXCR2 (Cxcr2Tm1Mwm/J), both in 
the C57BL/6J background, were obtained from The Jackson Laboratory. 
LysM-GFP+ mice in the C57BL/6J background were described previously 
(Yao et al., 2013). Mice lacking talin1 in myeloid cells (Tln1f/fLysMCre+) 
were generated by breeding Tln1f/f mice (Petrich et al., 2007) with LysMCre+ 
mice in the C57BL/6J background (Yao et al., 2013). Tln1f/fLysMCre 
mice were used as littermate controls for Tln1f/fLysMCre+ mice. Mice ex-
pressing talin1(L325R) in myeloid cells (Tln1L325R/fLysMCre+) were generat-
ing by breeding Tln1wt/L325R mice (Haling et al., 2011) with Tln1f/fLysMCre+ 
mice. Mice expressing talin1(W359A) in myeloid cells (Tln1W359A/fLysMCre+) 
were generating by breeding Tln1wt/W359A mice (Stefanini et al., 2014) with 
Tln1f/fLysMCre+ mice. Tln1wt/fLysMCre+ mice were used as littermate 
controls for Tln1L325R/fLysMCre+ and Tln1W359A/fLysMCre+ mice. All 
mice expressing Tln1 genotypes were backcrossed into the C57BL/6J back-
ground for at least five generations. All mice were 8–12 wk old at time 
of study.
talin1(L325R)-expressing neutrophils (Fig. 7 B). Talin1(L325R) 
supports platelet-mediated clot retraction when integrin 
IIb3 is activated by extracellular Mn2+ (Haling et al., 2011). 
Similarly, Tln1L325R/fLysMCre+ neutrophils exhibited nor-
mal SFK-dependent adhesion strengthening on fibrinogen or 
ICAM-1 when 2 integrins were activated by Mn2+ (Fig. 7, 
D and F). However, the inability of CXCL1 to trigger 2 
integrin–dependent arrest prevented ligand-triggered outside-
in signaling (Fig. 4 F), which for IIb3, requires separation 
of the TMDs (Zhu et al., 2007). Kindlin-3–deficient leuko-
cytes also have impaired adhesion strengthening (Feigelson 
et al., 2011; Moretti et al., 2013), probably from defects in 
both integrin clustering (Ye et al., 2013) and resulting outside-
in signaling.
A W359A mutation inhibits talin1 binding to the MD site 
of the 3 tail and, as a result, hinders secondary binding to the 
MP site. In contrast, the L325R mutation impairs binding to 
the MP site without affecting the affinity for the MD site 
(Wegener et al., 2007). Neutrophils expressing talin1(W359A), 
like neutrophils lacking talin1, were deficient in both selectin-
induced slow rolling and chemokine-induced arrest (Fig. 4, 
B and E), confirming that talin1 binding to the MD site of 
 tails is required to allosterically activate integrins (Tadokoro 
et al., 2003). The retention of selectin-induced slow rolling in 
neutrophils expressing talin1(L325R) supports the idea that 
binding to the MD site of the  tail permits talin to link in-
tegrins to cytoskeletal proteins such as actin and vinculin 
(Haling et al., 2011), although intact actin filaments are not 
required for slow rolling (Shao et al., 2012). The retention of 
slow rolling also suggests that shear forces applied to L2-
ICAM-1 bonds are sufficient for integrin extension (Chen 
et al., 2012). In static systems, the L325R mutation prevents 
the talin-induced tilting of the 3 transmembrane domain 
required for allosteric activation of IIb3 (Wegener et al., 
2007; Kim et al., 2012). Our finding that talin binding to the 
MP domain of the  subunit, which is blocked by the L325R 
mutation, is required for arrest indicates that the forces expe-
rienced during slow rolling are not sufficient to cause the 
headpiece opening associated with neutrophil arrest, even in 
the presence of chemokines. Thus, we propose that blocking 
talin’s ability to engage the 2 integrin MP domain prevents 
the force-mediated cytoskeleton-dependent conversion of the 
ICAM-1–engaged chemokine-primed, closed headpiece, to the 
open headpiece, even when kindlin-3 is present (Chen et al., 
2010; Schürpf and Springer, 2011; Alon and Feigelson, 2012; 
Shao et al., 2012).
We found that selectin-induced 2 integrin–mediated 
slow rolling is not sufficient for renal ischemia–reperfusion 
injury (Fig. 2) or for neutrophil emigration in response to 
other inflammatory stimuli (Figs. 3 and 6). Is selectin sig-
naling necessary if not sufficient? For example, does selectin 
engagement prime neutrophils to respond more readily to 
chemokines? Previous studies concluded that selectin signal-
ing cooperates with chemokine signaling to maximize neu-
trophil recruitment in models of acute inflammation (Zarbock 
et al., 2007, 2008; Mueller et al., 2010; Yago et al., 2010b; 
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LysM-GFP+ mice were mixed in a 1:1 ratio with bone marrow cells from 
Tln1f/fLysMCre, Tln1f/fLysMCre+, Tln1f/L325RLysMCre+, or Tln1f/wtLysMCre+ 
mice. The cells (4 × 106) were injected intravenously into lethally irradiated 
C57BL/6J mice. Intravital microscopy was performed 8 wk after bone mar-
row transplantation.
Flow chamber assay. Murine bone marrow leukocytes were isolated as 
described previously (Miner et al., 2008). In brief, bone marrow cells were 
isolated by gently flushing femurs and tibias with 10 ml Hanks’ balanced salt 
solution (HBSS) without Ca2+ or Mg2+. After lysing red blood cells in 150 mM 
NH4Cl, 10 mM NaHCO3, and 1 mM EDTA, the cells were washed with 
HBSS and resuspended at 2 × 106/ml in HBSS containing 1.26 mM Ca2+, 
0.81 mM Mg2+, and 0.5% human serum albumin.
35-mm polystyrene dishes were adsorbed with 10 µg/ml goat anti–
human IgM Fc antibody. In some experiments, 20 µg/ml murine ICAM-1–
Fc and 10 µg/ml murine CXCL1 were also adsorbed. After incubation at 
4°C overnight, the dishes were blocked with 1% human serum albumin, and 
then murine P-selectin or E-selectin–IgM was captured on the dishes. Bone 
marrow leukocytes were perfused over dishes mounted in a parallel-plate 
flow chamber at a wall shear stress of 1.0 dyn/cm2. After 5–10 min, rolling 
and arrested cells were analyzed using a video microscopy system coupled to 
Element digital image-analysis software (Nikon). Arrested cells were scored 
as round (round and bright) or spread (irregular and dark). To block chemo-
kine signaling through Gi-coupled receptors, some leukocytes were pre-
incubated with 200 ng/ml PTx at 37°C for 2 h.
Alternatively, leukocytes were introduced into chambers containing dishes 
with or without immobilized ICAM-1 and/or CXCL1 at 0.25 dyn/cm2 and 
then flow was stopped. After 15 min, unbound cells were removed with cell 
free-buffer at 0.25 dyn/cm2, and then nonspread (round and bright) and 
spread (irregular and dark) cells were counted using Element software.
In some experiments, dishes were coated with 2 µg/ml ICAM-1 or 
1 µg/ml fibrinogen and then blocked with 1% human serum albumin. Control 
surfaces were blocked with human serum albumin without adding ICAM-1 
or fibrinogen. Neutrophils were isolated from bone marrow leukocytes by a 
density gradient method (Yao et al., 2013). The neutrophils were incubated 
with the SFK inhibitor PP2 (20 µM), its inactive analogue PP3 (20 µM), or 
1 mM MnCl2. They were introduced into chambers at 0.25 dyn/cm2, and 
then flow was stopped. After 5 min, wall shear stress was increased step-wise 
every 30 s, and the number of remaining adherent cells was determined.
In other experiments, F(ab’)2 fragments of anti–murine 2 mAb 
GAME-46 were generated with a kit (Thermo Fisher Scientific). 50 µg/ml 
of GAME-46 F(ab’)2 were coated on 35-mm culture dishes. Neutrophils 
incubated with 20 µM PP2 or PP3 were introduced into the chamber at 
0.25 dyn/cm2 and then flow was stopped. After 15 min, unbound cells 
were removed with cell free-buffer at 0.25 dyn/cm2, and then nonspread 
(round and bright) and spread (irregular and dark) cells were counted using 
Element software.
Immunoprecipitation and Western blot. Bone marrow leukocytes were 
incubated with Fc receptor blocker for 20 min at room temperature (Xia 
et al., 2002). They were then serially incubated (20 min at 4°C) with 10 µg/ml 
biotinylated rat anti-Ly6G mAb and with 5 µg/ml streptavidin-conjugated 
magnetic beads (Xia et al., 2004). Ly6G-positive neutrophils bound to mag-
netic beads were isolated on a magnetic separator (Xia et al., 2004). Flow 
cytometry confirmed that >99% of the isolated cells expressed Ly6G. Neu-
trophil lysates were probed by Western blotting as described previously 
(Yago et al., 2010b), using murine mAb 8d4, which recognizes both talin1 
and talin2 (Zhang et al., 2008) or rabbit anti–-actin IgG, followed by 
HRP-conjugated goat anti–mouse IgG or goat anti–rabbit IgG. The talin/ 
-actin ratio was quantified by densitometry.
In other experiments, neutrophils were isolated from bone marrow leu-
kocytes by a density gradient (Yao et al., 2013). Cells (2 × 107) were incu-
bated with or without 100 ng/ml CXCL1 for 10 min at 37°C, centrifuged, 
and lysed in 200 µl of 1% Triton X-100, 125 mM NaCl, 50 mM Tris, 
pH 7.4, 10 mM EDTA, 2 mM PMSF, 0.1% SDS with a protease inhibitor 
Renal ischemia–reperfusion injury. Renal ischemia–reperfusion injury 
was performed as previously described (Block et al., 2012). Mice were anes-
thetized by intraperitoneal injection of 1.25% Avertin. The mice were placed 
on a heating pad to maintain a constant temperature. A midline abdominal 
incision was made and then both kidneys were exposed. Renal ischemia was 
induced by nontraumatic vascular clamps of both pedicles for 30 min. After 
clamps were released, the incision was closed in two layers with 3–0 sutures. 
Sham-operated mice underwent the same procedure without clamping. 
After 24 h, the mice were euthanized. Blood samples were taken by heart 
puncture, and kidneys were harvested to evaluate neutrophil infiltration in 
the kidneys. Creatinine levels in plasma were measured with a kit (Arbor 
Assays). To determine the number of infiltrated neutrophils into the kidneys, 
single-cell suspensions were obtained by straining the collected kidneys 
through a 40-µm nylon mesh strainer. The suspension was labeled with PE-
conjugated anti-Ly6G mAb for flow cytometric analysis. For histological 
analysis, the kidneys were fixed in 10% formalin, processed, and embedded 
in paraffin. Tissue sections were stained with hematoxylin and eosin. Tubu-
lar necrosis was evaluated by the percentage of tubules showing epithelial 
karyolysis, necrotic debris, or cast formation in 10–15 randomly selected 
sections at the corticomedullary junction and outer medulla from each group 
(Yamada et al., 2004). Tubular necrosis, examined at 40× magnification, was 
scored as follows: 0, none; 1+, <10%; 2+, 10–25%; 3+, 26–45%; 4+, 46–
75%; 5+, >76%. The mean of the scores from the three morphological pa-
rameters in each group was used for statistical analysis. To assess neutrophil 
infiltration into the kidneys, kidneys were fixed in 4% paraformaldehyde 
overnight at 4°C, and then transferred into 20% sucrose overnight at 4°C for 
cryoprotection. Fixed tissues were mounted in OCT compound (Tissue-
Tek 4583). After fixation in acetone at 20°C for 2 min, 5-µm cryosections 
were rinsed with PBS containing 0.01% saponin, incubated with Protein 
Block serum-free buffer (Dako) at room temperature for 60 min, and then 
incubated with rat anti–murine Ly6G mAb diluted in immunostain enhancer 
(Thermo Fisher Scientific) overnight at 4°C. The tissue sections were stained 
with Alexa Fluor 488–conjugated donkey anti–rat IgG antibody diluted in 
Protein Block buffer with 0.01% saponin at room temperature for 1 h. Mount-
ing medium was then added to the slides. The images in the slides were visual-
ized on an Axiovert 200M (Carl Zeiss) microscope at 63× magnification, and 
captured by a Carl Zeiss AxioCam MRm Rev. 3.0 camera using acquisition 
software AxioVision Ver. 4.8 (Carl Zeiss).
Thioglycollate-induced peritonitis. Neutrophil emigration into the 
thioglycollate-challenged peritoneum was performed as previously described 
(Yago et al., 2010b). Mice were injected intraperitoneally with 1 ml of 4% 
thioglycollate. Some mice received 4 µg PTx intravenously 2 h before thio-
glycollate injection. After 4 h, peritoneal cells were collected with 10 ml 
PBS containing 0.1% BSA and 5 mM EDTA, and the cells were analyzed by 
flow cytometry. Neutrophils were counted based on scatter properties and 
expression of Ly6G.
Competitive neutrophil recruitment assay. Competitive neutrophil re-
cruitment was measured as previously described (Yago et al., 2010b). Bone 
marrow leukocytes from control mice (Tln1f/fLysMCre or Tln1f/wt-
LysMCre+) or experimental mice (Tln1f/fLysMCre+ or Tln1f/L325RLysMCre+) 
were labeled with red (PKH26) or green (PKH67) dye. The labeled cells 
were resuspended in HBSS at 108 cells/ml and mixed at a 1:1 ratio. Some la-
beled cells and recipient C57BL/6J mice were pretreated with PTx. Recipi-
ent mice were injected with 1 ml 4% thioglycollate intraperitoneally and, 
after 2 h, with 200 µl of the labeled cell mixture retroorbitally. After another 
2 h, blood was collected. The mice were sacrificed, and peritoneal cells were 
collected with 10 ml PBS containing 0.1% BSA and 5 mM EDTA. Neutro-
phils in blood and peritoneal exudate were counted. The data were plotted 
as the ratio of PKH26-labeled neutrophils from the experimental population 
compared with PKH67-labeled neutrophils from the control population.
Bone marrow chimeras. Bone marrow chimeras were generated as 
described previously (Yao et al., 2013). In brief, bone marrow cells from 
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into a single optic cable, and introduced into the CSU-X1 head. Fluor-
escence signals were detected through three emission filters of ET525/50, 
ET605/52, and ET700/75 controlled by an ASI FW-1000 Filterwheel (Ap-
plied Scientific Instrumentation). A 512 × 512 pixel back-thinned EMCCD 
camera (C9100-13; Hamamatsu) was used for acquisition of the fluorescent 
images. The spinning disk confocal microscope was driven by the National 
Institutes of Health acquisition software Micromanager. The images were 
captured by Micromanager and analyzed with ImageJ software.
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